(RTTNews) - Shares of Becton, Dickinson and Company (BDX) gained 5% in the extended trading session on Friday after the medical technology company announced that the updated BD Alaris Infusion System ...

The FDA approved BD's (Becton, Dickinson, and Company) (NYSE:BDX) BD Alaris Infusion System with 510(k) clearance, which enables both remediation and a return to full commercial operations for the ...

Becton, Dickinson and Company BDX, popularly known as BD, recently received the FDA’s 510(k) clearance for its updated BD Alaris Infusion System. This is expected to enable both remediation and a ...

BD (Becton, Dickinson and Company), a leading global medical technology company, announced that the updated BD Alaris Infusion System has received 510(k) clearance from the US Food and Drug ...

This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. BD has expanded a Class I Alaris recall to cover 15 ...

Please provide your email address to receive an email when new articles are posted on . The FDA granted 510(k) clearance to Becton Dickinson’s updated Alaris infusion pump, allowing the company to ...

BD is recalling hundreds of thousands of its Alaris infusion pumps and vital sign monitors due to multiple system faults, including software- and user-related issues. According to the FDA, the errors ...

A new group of recalls for a repair piece installed in some of BD’s Alaris infusion pumps joins more than a dozen others on the long list of serious recalls involving the device in the last decade.

FRANKLIN LAKES, N.J., July 21, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the updated BD Alaris™ Infusion ...